about
Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer XenograftsInhibition of c-Abl kinase activity renders cancer cells highly sensitive to mitoxantroneIncreased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy.Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors.Differential roles of fibroblast growth factor receptors (FGFR) 1, 2 and 3 in the regulation of S115 breast cancer cell growthDNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cellsMultiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasisToll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo.Tumor models for prostate cancer exemplified by fibroblast growth factor 8-induced tumorigenesis and tumor progression.Oncolytic alphavirus SFV-VA7 efficiently eradicates subcutaneous and orthotopic human prostate tumours in mice.Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer.Telomeric G-quadruplex-forming DNA fragments induce TLR9-mediated and LL-37-regulated invasion in breast cancer cells in vitro.Tracer level electrophilic synthesis and pharmacokinetics of the hypoxia tracer [(18)F]EF5.FGF-8b induces growth and rich vascularization in an orthotopic PC-3 model of prostate cancer.Hypoxia regulates Toll-like receptor-9 expression and invasive function in human brain cancer cells in vitro.Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer.FGF-8 is involved in bone metastasis of prostate cancer.The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility.Lipid Bilayer-Gated Mesoporous Silica Nanocarriers for Tumor-Targeted Delivery of Zoledronic Acid in Vivo.Evaluation of (68)Ga-labeled peptide tracer for detection of gelatinase expression after myocardial infarction in rat.Galactoglucomannan-rich hemicellulose extract from Norway spruce (Picea abies) exerts beneficial effects on chronic prostatic inflammation and lower urinary tract symptoms in vivo.6-[18F]fluoro-L-DOPA uptake in the rat pancreas is dependent on the tracer metabolism.Alendronate-induced disruption of actin cytoskeleton and inhibition of migration/invasion are associated with cofilin downregulation in PC-3 prostate cancer cellsEvaluation of [Ga]Ga-DOTA-TCTP-1 for the Detection of Metalloproteinase 2/9 Expression in Mouse Atherosclerotic PlaquesDovitinib dilactic acid reduces tumor growth and tumor-induced bone changes in an experimental breast cancer bone growth modelCharacterization a model of prostatic diseases and obstructive voiding induced by sex hormone imbalance in the Wistar and Noble ratsChronic nonbacterial prostate inflammation in a rat model is associated with changes of gut microbiota that can be modified with a galactoglucomannan-rich hemicellulose extract in the dietγ-(S)-Guanidinylmethyl-Modified Triplex-Forming Peptide Nucleic Acids Increase Hoogsteen-Face Affinity for a MicroRNA and Enhance Cellular Uptake
P50
Q27304359-E0E7F5F2-7D47-488F-8C4F-D80A6A4FC7C2Q27313997-08DBFAF7-4EFC-4429-8854-FCD38764740AQ27853341-FC654040-6DB6-4E42-B3B4-AF2D4AE18734Q33326045-36CBB64E-1F37-42D9-8A7E-F6AAF8D5202CQ33509896-0E816C5F-C0E5-4BB9-B23A-C25C3BF5B7FEQ34490810-59C63B6C-1780-4ED7-AB75-EE456A71B850Q34549200-AE213A07-2E2E-4B23-BD43-A0E96B345875Q36772312-79D6A212-E57A-40FA-A943-A28DFDBD7712Q37699431-1A515E88-E42A-4D84-88B4-A20016EEBCC5Q38194314-899E67AC-0639-43C6-9B2E-469EA01D4F3DQ38701864-039983E6-C59B-49F9-89B2-F669FCB5BA71Q38794482-AB68B683-E45A-4BF0-96A1-A3D564842F53Q38802341-0F3B71FD-EBB9-4DAE-9016-4F50C1B4B797Q39568484-C0FEA8F8-D62A-4270-A1BC-56D142BC2B5FQ39856809-1748C949-4008-4112-9F8D-E3A87CB490A5Q40893702-687431DF-80E0-495A-A085-B346536B18B5Q41497232-B123BE5A-15EE-4ED1-9CBB-872F1C79AC6EQ41923347-46C51C7B-9DFF-4990-92D1-61B8EBA0B432Q43881646-BF18CFE6-91F4-4514-A5B2-11998BB874E1Q44801719-07C267ED-0492-4991-8616-5F1D1D468EBFQ47888139-663D5E53-9B24-4E31-B2F7-B77FA65904B1Q51030206-1A34EC5E-3F59-43D5-A587-607A8B802805Q52888503-B98446F1-F616-4940-A765-1264402A62A2Q54621041-F7D60341-9B27-4112-954B-5B2CCA89E3FCQ58704639-87616BA3-B7E5-4006-9480-36A6D036DC10Q60923019-E69FD66C-B051-4799-A9B3-051009B0FE8CQ64076390-018DE336-1DA0-4D67-8492-F176D8B45377Q64246607-0335E2D8-382A-4595-8632-420E4FC4E58FQ91760087-E89B371F-AC8B-46C6-873E-4EBF79254247Q92807243-4B1F5184-5F24-4E58-8E97-1964B803B242
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Johanna M Tuomela
@ast
Johanna M Tuomela
@en
Johanna M Tuomela
@es
Johanna M Tuomela
@nl
type
label
Johanna M Tuomela
@ast
Johanna M Tuomela
@en
Johanna M Tuomela
@es
Johanna M Tuomela
@nl
prefLabel
Johanna M Tuomela
@ast
Johanna M Tuomela
@en
Johanna M Tuomela
@es
Johanna M Tuomela
@nl
P106
P21
P31
P496
0000-0003-4390-4563